In the published article, there was an error in Figure 2 as published. The 3-month seizure freedom rate in OXC group should be 80.7% in the original figure. The 6-month seizure freedom rate in OXC group should be 43/55. The corrected Figure 2 and its caption appear below.
FIGURE 2.
Seizure-response status and seizure-free status on PER/OXC monotherapy. (A) OP3; (B) OP6; and (C) OP12. Seizure free: seizure freedom; Sz reduce ≥75%: seizure reduction ≥75%; Sz reduce ≥50%: seizure reduction ≥50%.
In the published article, there was also an error in the text. The 6-month seizure freedom rate in OXC group should be 43/55.
A correction has been made to 3 Result, 3.2 Primary endpoint, paragraph 1. This sentence previously stated:
“In the PPS, 78.1% (50/64, 95% CI: 66.0%–87.5%) of children in the PER group and 78.2% (43/56) in the OXC group were seizure-free at 6 months.”
The corrected sentence appears below:
“In the PPS, 78.1% (50/64, 95% CI: 66.0%–87.5%) of children in the PER group and 78.2% (43/55) in the OXC group were seizure-free at 6 months.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.